HNN3.0
Register
Register
Register

Arrakis Bio

Start-up

www.arrakis.bioModi'in, Israel

About

Arrakis Bio focuses on biomanufacturing critical human-identical ECM biomaterials, a key structural foundation for next-generation biomedical technologies for human-predictive in-vitro platforms.

Our industrially scalable cell-culture platform delivers human Collagen and ECM proteins with guaranteed tissue specificity, non-immunogenicity, and batch consistency. This sets a new standard for quality and biocompatibility in human-predictive in-vitro platforms.

Representatives

CEO

Arrakis Bio

Marketplace (1)

  • Project cooperation

    Human Collagen and Xeno-free Human ECM for Medical Applications

    Arrakis Bio can support projects that are interested in Xeno-free Human Collagen and Human ECM for Medical and Research use cases

    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    Author

    CEO at Arrakis Bio

    Modi'in, Israel